Edition:
United States

Oasmia Pharmaceutical AB (OASM.ST)

OASM.ST on Stockholm Stock Exchange

3.85SEK
8:55am EST
Change (% chg)

-0.04kr (-0.90%)
Prev Close
3.88kr
Open
3.93kr
Day's High
3.94kr
Day's Low
3.81kr
Volume
135,619
Avg. Vol
625,352
52-wk High
7.04kr
52-wk Low
2.19kr

Select another date:

Mon, Feb 19 2018

BRIEF-Oasmia Pharma says all patients have been treated in two ongoing studies with Docecal

* REG-OASMIA PHARMACEUTICAL’S DOCECAL PROGRAM ACHIEVES SIGNIFICANT DEVELOPMENT MILESTONE

BRIEF-Oasmia receives marketing approval for Paclical in Kazakhstan

* OASMIA PHARMACEUTICAL RECEIVES MARKETING APPROVAL FOR PACLICAL® IN KAZAKHSTAN Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Oasmia Pharmaceutical Q2 operating loss shrinks

* OASMIA PHARMACEUTICAL AB Q2 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 1,651 COMPARED TO TSEK 56 IN THE SECOND QUARTER THE PREVIOUS YEAR ​

BRIEF-Oasmia completes 28 mln SEK private placement of new convertible instruments

* OASMIA HAS COMPLETED A PRIVATE PLACEMENT OF NEW CONVERTIBLE INSTRUMENTS IN A TOTAL AMOUNT OF SEK 28,000,000

BRIEF-Oasmia CFO resigns

* Oasmia Pharmaceutical Ab Announces Resignation Of Its Chief Financial Officer

BRIEF-Nexttobe extends loan to Oasmia Pharmaceutical

* Nexttobe extends loan to Oasmia Pharmaceutical Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Oasmia Q1 operating loss lower

* Says Q1 operating loss was TSEK 28,421 compared to TSEK 32,343 in Q1 previous year

Select another date: